A
Aura Biosciences, Inc. (AURA)
NGM – Real Time Price. Currency in USD
7.00
+0.14 (2.04%)
At close: Jun 26, 2026, 4:00 PM EDT
7.14
+0.14 (2.00%)
After-hours: Jun 26, 2026, 6:00 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NGM – Real Time Price. Currency in USD
7.00
+0.14 (2.04%)
At close: Jun 26, 2026, 4:00 PM EDT
7.14
+0.14 (2.00%)
After-hours: Jun 26, 2026, 6:00 PM EDT
Revenue breakdown data has not been calculated yet.
No Data
There are no news for this stock.
Company's cash reserves $84.8M significantly exceed its total debt $17.0M, ensuring strong financial flexibility
Total current assets $118.5M exceed Total current liabilities $16.7M, highlighting excellent liquidity
Debt-to-equity ratio (0.2) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$30.0M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 7.09 | 6.05 | 10 | |
| Quick ratio | 7.09 | 5.63 | 10 | |
| Debt to Equity | 0.16 | 0.30 | 9.0 | |
| Debt to Assets | 0.12 | 1.04 | 8.0 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 7.6 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | -1M | -1M | -1M | -1M | -1M |
| Operating Income | -60M | -85M | -96M | -113M | -119M |
| Net Income | -59M | -76M | -87M | -106M | -112M |
| EBITDA | -59M | -84M | -95M | -112M | -117M |
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Gross margin % | N/A | -11.73 | 1.0 | |
| Operating margin % | N/A | -24.60 | 1.0 | |
| Net margin % | N/A | -172.20 | 1.0 | |
| EBITDA margin % | N/A | -201.27 | 1.0 | |
| Cash flow margin % | N/A | -156.39 | 1.0 | |
| Weighted average score | 1.0 | |||
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | 20.21 | 5.5 |
| Next quarter | N/A | 8.13 | 3.5 |
| Current year | N/A | 9.38 | 3.5 |
| Next year | N/A | -4.55 | 1.0 |
| Weighted average score | 3.4 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | -31.78 | -47.05 | -45.28 | 3.3 |
| Y/Y | 999 | -22.56 | 9.09 | -27.4 | 4.5 |
| 3y average | 999 | -21.97 | 3.43 | -15.5 | 4.0 |
| 5y average | 999 | -38.26 | 22.1 | -29.07 | 5.5 |
| Weighted average score | 4.3 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |